成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Wuhan Jingkangen Biomedical Technology Co., Ltd

Wuhan Jingkangen Biomedical Technology Co., Ltd

Current Location: HOME >> Product
Product Categories
Country: China
Tel: 13720134139 +86 -0-15871494362
Mobile: 13720134139
E-mail:
QQ:
Skype: Chat Now!
Product Name MF CAS Details
Cixutumumab 947687-12-9 Details
Lemalesomab 250242-54-7 Details
Ecromeximab 292819-64-8 Details
Farletuzuma 896723-44-7 Details
Research Grade Bivatuzumab Details
reslizumab 241473-69-8 Details
Research Grade Pintumomab Details
SU5408 C18H18N2O3 15966-93-5 Details
Pritumumab 499212-74-7 Details
Oportuzumab Monatox 945228-48-8 Details
Tremelimumab 745013-59-6 Details
Tucotuzumab Celmoleukin 339986-90-2 Details
Tefibazumab 521079-87-8 Details
Etaracizumab 892553-42-3 Details
Iratumumab 640735-09-7 Details
Volociximab 558480-40-3 Details
Libivirumab 569658-79-3 Details
notuzumab 635715-01-4 Details
Belimumab 356547-88-1 Details
Bapineuzumab 648895-38-9 Details
Panobacumab 885053-97-4 Details
Otelixizumab 881191-44-2 Details
Obinutuzumab 949142-50-1 Details
Denosumab C6404H9912N1724O2004S50 615258-40-7 Details
Yttrium (90Y) Tacatuzumab Tetraxetan 476413-07-7 Details
Exbivirumab 569658-80-6 Details
Raxibacumab 565451-13-0 Details
Elsilimomab 468715-71-1 Details
Pagibaximab 595566-61-3 Details
Canakinumab 914613-48-2 Details
Citatuzumab Bogatox 945228-49-9 Details
Urtoxazumab 502496-16-4 Details
Besilesomab 537694-98-7 Details
Epitumomab 372075-37-1 Details
Ibalizumab 680188-33-4 Details
Robatumumab 934235-44-6 Details
Elotuzumab 915296-00-3 Details
Teneliximab 395639-53-9 Details
Research Grade Taplitumomab Details
Research Grade Anatumomab Details
Erlizumab 211323-03-4 Details
Vapaliximab 336801-86-6 Details
Research Grade Sibrotuzumab Details
Figitumumab 943453-46-1 Details
Alacizumab 934216-54-3 Details
Fresolimumab 948564-73-6 Details
Ustekinumab 815610-63-0 Details
Andarine/S-4 C19H18F3N3O6 401900-40-1 Details
YK11 C25H34O6 431579-34-9 Details
Ibutamoren mesylate/MK677 C28H40N4O8S2 159752-10-0 Details
Infliximab 170277-31-3 Details
Lumiliximab 357613-86-6 Details
Research Grade Clenoliximab 182912-58-9 Details
Ganitumab 905703-97-1 Details
Bertilimumab 375348-49-5 Details
Briakinumab 339308-60-0 Details
Mapatumumab 658052-09-6 Details
ofatumumab 679818-59-8 Details
Ertumaxomab 509077-99-0 Details
Ipilimumab 477202-00-9 Details
Metelimumab 272780-74-2 Details
Regavirumab 153101-26-9 Details
Conatumumab 896731-82-1 Details
Research Grade Lerdelimumab 285985-06-0 Details
Stamulumab 705287-60-1 Details
Zanolimumab 652153-01-0 Details
Tenatumomab 1412891-40-7 Details
Anrukinzumab 910649-32-0 Details
Research Grade Camidanlumab 921618-45-3 Details
Tigatuzumab 918127-53-4 Details
Efungumab 762260-74-2 Details
Research Grade Golimumab 476181-74-5 Details
LGD3033 C16H14ClF3N2O 917891-35-1 Details
SR9009 C20H24ClN3O4S 1379686-30-2 Details
Vosilasarm/RAD140 C20H16ClN5O2 1182367-47-0 Details
Galiximab 357613-77-5 Details
Keliximab 174722-30-6 Details
Research Grade Priliximab 147191-91-1 Details
Tralokinumab 1044515-88-9 Details
Adecatumumab 503605-66-1 Details
Tuvirumab 138660-97-6 Details
ocrelizumab C19H16N2O5 637334-45-3 Details
Research Grade J695 Details
Research Grade Otilimab 1638332-55-4 Details
Zalutumumab 667901-13-5 Details
Racotumomab 946832-34-4 Details
Lexatumumab 845816-02-6 Details
Nebacumab 138661-01-5 Details
Catumaxomab 509077-98-9 Details
Research Grade HuCC49 823788-82-5 Details
Panitumumab 339177-26-3 Details
Gantenerumab 1043556-46-2 Details
Tanezumab 880266-57-9 Details
Dacetuzumab 880486-59-9 Details
Cetuximab C107H179N35O36S7 205923-56-4 Details
LGD4033 C14H12F6N2O 1165910-22-4 Details
Maribavir C15H19Cl2N3O4 176161-24-3 Details
Acadesine C9H14N4O5 2627-69-2 Details
Cardarine/GW501516 C21H18F3NO3S2 317318-70-0 Details
Enobosarm/MK2866 C19H14F3N3O3 841205-47-8 Details
Product Total: Product Page:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58